Novo Nordisk A/S
做多

NVO: Weekly Falling Wedge Lines Up With Key FVG

191
Novo Nordisk (NVO) is basing after an extreme drawdown — the stock ran from ~$40 to ~$150 through 2024, then gave nearly all of it back in a sharp decline back to the low $40s on GLP-1 competition and trial-data pressure.

Price just printed an +11.30% weekly reversal candle, closing at 48.07, and the pattern detector has flagged the recovery structure off the bottom as a Bullish Pennant.

Setup — Weekly Bullish Pennant
Entry: 49.96
Stop: 24.83
Target: 150.49
Risk:Reward: ~4R
R:R Quality: 80% | Pivot Depth: 100% | 26 bars since the pennant break

Price is sitting just under the 49.96 trigger after this week's reversal candle — not yet confirmed above the entry line.

Momentum
The custom ML RSI is climbing out of the high-30s/low-40s zone with a rising trendline under the recent lows, supporting the base-building thesis alongside price.

Invalidation
A weekly close back below the 24.83 stop invalidates the pennant thesis and would suggest the downtrend is resuming rather than basing.

Bias
Bullish above 49.96 confirmation, targeting a measured move back toward 150.49. This is a multi-month, high R:R swing setup — not a quick trade.

This is technical analysis for educational purposes, not financial advice. Do your own research and manage risk accordingly.

免責聲明

這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。